Topics
MERCK & CO. INC., $98.05, is a buy. The drugmaker (symbol MRK on New York) is a pharmaceutical leader in oncology, acute-care and animal health drugs as well as vaccines.
Merck is now making a foray into the lucrative obesity market. The company has announced that it is licensing global rights to an investigational oral GLP-1 receptor, HS-10535, from Chinese biotech Hansoh Pharma.
For the exclusive global rights to develop, manufacture and commercialize this pre-clinical candidate, Merck will make an upfront payment of $112 million to Hansoh Pharma, with Hansoh also being entitled to receive up to $1.9 billion in milestone payments and royalties on sales....
Merck is now making a foray into the lucrative obesity market. The company has announced that it is licensing global rights to an investigational oral GLP-1 receptor, HS-10535, from Chinese biotech Hansoh Pharma.
For the exclusive global rights to develop, manufacture and commercialize this pre-clinical candidate, Merck will make an upfront payment of $112 million to Hansoh Pharma, with Hansoh also being entitled to receive up to $1.9 billion in milestone payments and royalties on sales....
CANADIAN TIRE CORP., $153.58, Toronto symbol CTC.A, is a top pick for 2024.
The company operates 502 Canadian Tire stores, which sell automotive parts and services, and household and sporting goods; franchisees run most of the locations. The company’s other operations also enrich its outlook....
The company operates 502 Canadian Tire stores, which sell automotive parts and services, and household and sporting goods; franchisees run most of the locations. The company’s other operations also enrich its outlook....
PFIZER INC., $26.37, New York symbol PFE, is your #1 Income Buy for 2024.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).
With the March 2025 payment, Pfizer will raise your quarterly dividend by 2.4%....
IMPERIAL OIL LTD., $88.61, Toronto symbol IMO, is a buy.
This company gets over 90% of its production from oil sands operations in Alberta. Imperial also has conventional oil and natural gas operations in the West and holds stakes in offshore projects in Atlantic Canada.
Its other operations include three refineries (one in Alberta, two in Ontario) and a petrochemical plant in Sarnia, Ontario.
Imperial now plans to spend between $1.9 billion and $2.1 billion on capital upgrades and exploration in 2025....
This company gets over 90% of its production from oil sands operations in Alberta. Imperial also has conventional oil and natural gas operations in the West and holds stakes in offshore projects in Atlantic Canada.
Its other operations include three refineries (one in Alberta, two in Ontario) and a petrochemical plant in Sarnia, Ontario.
Imperial now plans to spend between $1.9 billion and $2.1 billion on capital upgrades and exploration in 2025....
You Can See Our High-Growth Dividend Payer Portfolio for January 2025 Here.
You can’t fake a record of dividends....
PEMBINA PIPELINE CORP. $52 is a buy. The company (Toronto symbol PPL; High-Growth Dividend Payer Portfolio; Utilities sector; Shares outstanding: 580.5 million; Market cap: $30.2 billion; Dividend yield: 5.3%; Dividend Sustainability Rating: Above Average; www.pembina.com) operates pipelines that carry half of Alberta’s conventional oil and almost all of B.C.’s oil.
The company has paid dividends continuously since 1997....
The company has paid dividends continuously since 1997....
To conserve cash for new projects, Emera has slowed the pace of its planned dividend hikes. However, the new policy will make the payment more sustainable. At the same time, the company’s new projects will spur its growth.
EMERA INC. $54 is a buy. The company (Toronto symbol EMA; Income-Growth Portfolio, Utilities sector; Shares outstanding: 292.8 million; Market cap: $15.8 billion; Dividend yield: 5.4%; Dividend Sustainability Rating: Highest; www.emera.com) owns 100% of Nova Scotia Power, that province’s main electricity supplier....
EMERA INC. $54 is a buy. The company (Toronto symbol EMA; Income-Growth Portfolio, Utilities sector; Shares outstanding: 292.8 million; Market cap: $15.8 billion; Dividend yield: 5.4%; Dividend Sustainability Rating: Highest; www.emera.com) owns 100% of Nova Scotia Power, that province’s main electricity supplier....
You Can See Our WSSF Conservative Growth Portfolio For January 2025 Here.
We designed our TSINetwork Ratings to give you an idea of the investment quality and risk in stocks we recomm...
NUTRIEN LTD. $65 is a buy. The company (Toronto symbol NTR; Cyclical-Growth Payer Portfolio, Resources sector; Shares outstanding: 493.4 million; Market cap: $32.1 billion; Dividend yield: 4.8%; Dividend Sustainability Rating: Above Average; www.nutrien.com) is the world’s largest producer of agricultural fertilizers.
With the April 2024 payment, the company raised your quarterly dividend by 1.9%....
With the April 2024 payment, the company raised your quarterly dividend by 1.9%....
SONY GROUP CORP. ADRs $21 (www.sony.com) is a hold. For the fiscal 2025 second quarter, ended September 30, 2024, the Japanese conglomerate reported a sales rise of 6.3%, to $20.18 billion from $18.98 billion a year earlier. That’s largely due to stronger demand for its PlayStation video gaming products....